Behaviour change:
The key to unlocking potential in rare diseases
Alpharmaxim Healthcare Communications
Rebuilding beliefs, redefining behaviours:
a necessary shift for medical marketing
At the World Orphan Drug Congress 2021 (November 2021), we presented this poster to international healthcare professionals and patient advocates, driving conversations about the urgent need for behavioural science to become an integrated part of the way we approach tailored healthcare communications in rare diseases.
If you are interested in hearing more about this approach to rare disease medical communications, or wider applications in the healthcare sector, get in touch with our team.
Talk to us about how we can transform your communications
Alpharmaxim in the press
With many organisations beginning to invest in behavioural science, we’ve been shouting in the press about the benefits for pharma companies.
Ten ways that internal communications can boost your business
Employee engagement, brand alignment, sharing expertise to solve problems: these are all things that internal communications can achieve.
It's time for behavioural science to take centre stage in health communications
Progress brings new challenges, and help is needed. It might be time for behavioural science to play a bigger part than ever before.
